Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 135 entries
View as:

Assess Burden of Disease Among Kidney Transplant Recipients With Chronic Active Antibody Mediated Rejection

Phase: N/A Priority: Normal
NCT ID: NCT05452317 Org: User:
Start: 07/14/22 End: 04/04/23 Due: 04/04/24

A Safety and Efficacy Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B

Phase: N/A Priority: Normal
NCT ID: NCT01496274 Org: User:
Start: 02/29/12 End: - Due: -

Health Related Quality of Life of Youth and Young Adults With Hemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT01034904 Org: User:
Start: 10/31/09 End: 11/30/13 Due: 11/30/14

Pharmacokinetics and Pharmacodynamics of Two Prolonged-release Formulations of Vamifeport in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06726863 Org: User:
Start: 11/22/24 End: 02/01/25 Due: 02/01/26

Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products

Phase: N/A Priority: Normal
NCT ID: NCT06738485 Org: User:
Start: 01/09/25 End: 06/26/26 Due: 06/26/27

Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10

Phase: N/A Priority: Normal
NCT ID: NCT00168038 Org: User:
Start: 12/31/04 End: 02/28/06 Due: 02/28/07

Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

Phase: N/A Priority: Normal
NCT ID: NCT01458171 Org: User:
Start: 04/30/11 End: 04/30/12 Due: 04/30/13

A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction

Phase: N/A Priority: Normal
NCT ID: NCT02742103 Org: User:
Start: 08/31/16 End: 06/30/17 Due: 06/30/18

CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema

Phase: N/A Priority: Normal
NCT ID: NCT05819775 Org: User:
Start: 05/30/23 End: 12/10/25 Due: 12/10/26

HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients

Phase: N/A Priority: Normal
NCT ID: NCT03569891 Org: User:
Start: 06/27/18 End: 03/19/25 Due: 03/19/26

A Safety and Efficacy Study of a Recombinant Factor IX in Patients With Severe Hemophilia B

Phase: N/A Priority: Normal
NCT ID: NCT01361126 Org: User:
Start: 07/31/11 End: 07/31/12 Due: 07/31/13

Safety and Tolerability Study of Liquid Alpha1 Proteinase Inhibitor (API) in Subjects With Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT01347190 Org: User:
Start: 04/30/11 End: 08/31/11 Due: 08/31/12

Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00708435 Org: User:
Start: 06/30/08 End: 11/30/10 Due: 11/30/11

Evaluating the Effectiveness of Telemonitoring System in the Management of Patients With CIDP

Phase: N/A Priority: Normal
NCT ID: NCT03779828 Org: User:
Start: 11/27/17 End: 06/03/19 Due: 06/03/20

An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure

Phase: N/A Priority: Normal
NCT ID: NCT00803101 Org: User:
Start: 02/28/09 End: 02/28/13 Due: 02/28/14

Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)

Phase: N/A Priority: Normal
NCT ID: NCT01461018 Org: User:
Start: 10/31/11 End: 07/31/14 Due: 07/31/15

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)

Phase: N/A Priority: Normal
NCT ID: NCT01545076 Org: User:
Start: 03/31/12 End: 09/30/16 Due: 09/30/17

Dose Confirmation Trial of AAV5-hFIXco-Padua

Phase: N/A Priority: Normal
NCT ID: NCT03489291 Org: User:
Start: 07/24/18 End: 09/21/23 Due: 09/21/24

An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B

Phase: N/A Priority: Normal
NCT ID: NCT06008938 Org: User:
Start: 06/15/23 End: 08/31/43 Due: 08/31/44

Retrospective Chart Review of Subcutaneous IgG Use in Infants

Phase: N/A Priority: Normal
NCT ID: NCT01166074 Org: User:
Start: 05/31/10 End: 12/31/10 Due: 12/31/11

A Safety, Efficacy and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Children With Hemophilia B

Phase: N/A Priority: Normal
NCT ID: NCT01662531 Org: User:
Start: 01/31/13 End: - Due: -

Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID)

Phase: N/A Priority: Normal
NCT ID: NCT00168012 Org: User:
Start: 09/30/04 End: 09/30/05 Due: 09/30/06

Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04638634 Org: User:
Start: 02/02/21 End: 06/09/21 Due: 06/09/22

Rabies Immune Plasma Booster Study

Phase: N/A Priority: Normal
NCT ID: NCT01063140 Org: User:
Start: 01/31/09 End: 05/31/10 Due: 05/31/11

Registry of Patients With Von WilLEbrand Disease Treated With Voncento®

Phase: N/A Priority: Normal
NCT ID: NCT04657887 Org: User:
Start: 11/23/15 End: 12/31/23 Due: 12/31/24